B. Schlegelberger et al., CYTOGENETIC FINDINGS AND RESULTS OF COMBINED IMMUNOPHENOTYPING AND KARYOTYPING IN HODGKINS-DISEASE, Leukemia, 8(1), 1994, pp. 72-80
Cytogenetic studies were performed in 21 cases of Hodgkin's disease. F
ourteen cases revealed chromosomally aberrant clones which could be fu
lly described in 12 cases. Two cases showed different unrelated clones
and five cases only single cell aberrations. Recurrent breakpoints we
re 1p13/21 (six cases), 7q32/34 (five cases), 2p16/21 and 19p13 (four
cases each), 4q25/28, 6q15/21 and 12q22/23 (three cases each). In two
cases, a translocation between band 19p13 and band 14q11 or 14q32 was
found. This finding may indicate that an unknown oncogene in 19p13 is
activated by juxtaposition next to a T-cell receptor or immunoglobulin
gene in 14q11 or 14q32, respectively. In eight cases each, total or p
artial monosomy 4 or 6 was present suggesting that tumor suppressor ge
nes in 4q or 6q play a role in tumor development in Hodgkin's disease.
Moreover, the aberrant clones lacked the Y-chromosome in men and the
second X-chromosome in women in eight out of nine and in two out of th
ree cases, respectively. Although different cell populations, especial
ly T cells, showed mitotic activity in unstimulated short term culture
, combined immunophenotyping and karyotyping unequivocally demonstrate
d that CD30 and CD15 positive Hodgkin and Sternberg-Reed cells represe
nted the chromosomally aberrant clones.